Glimepiride Metformin Hydrochloride Tablet

Product Description

Glimepiride + Metformin Hydrochloride Tablets

Composition:
Each uncoated bilayered tablet contains:

• Glimepiride 1 mg / 2 mg / 4 mg (as per strength)

• Metformin Hydrochloride 500 mg / 850 mg / 1000 mg (Sustained Release or Immediate Release as per formulation)

Description:

A rational fixed-dose combination of Glimepiride, a sulfonylurea that stimulates insulin release, and Metformin, a biguanide that reduces hepatic glucose production and improves insulin sensitivity. This combination provides complementary mechanisms to effectively manage blood glucose levels in patients with Type 2 Diabetes Mellitus (T2DM).

Indications:

• Type 2 Diabetes Mellitus (T2DM)

• Patients inadequately controlled on monotherapy

• First-line dual therapy in insulin-resistant patients

Benefits:

Dual mechanism for optimal glycemic control
Improves insulin sensitivity and -cell response
Reduces fasting and postprandial blood glucose levels
Convenient once or twice-daily dosing

Dosage:

As prescribed by the physician.
Usually taken once or twice daily, preferably with meals to minimize GI upset.

Storage:

Store in a cool, dry place. Protect from light and moisture.